BlackRock, Inc. 13D and 13G filings for Anavex Life Sciences Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-25 5:01 pm Purchase |
2023-12-31 | 13G | Anavex Life Sciences Corp. AVXL |
BLACKROCK INC BLK |
6,671,075 8.100% |
1,092,916 (+19.59%) |
Filing |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | Anavex Life Sciences Corp. AVXL |
BLACKROCK INC BLK |
5,578,159 7.200% |
315,493 (+5.99%) |
Filing |
| 2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | Anavex Life Sciences Corp. AVXL |
BLACKROCK INC BLK |
5,262,666 6.900% |
1,583,903 (+43.06%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Anavex Life Sciences Corp. AVXL |
BLACKROCK INC BLK |
3,678,763 5.500% |
768,542 (+26.41%) |
Filing |